Pannexin 3 and connexin 43 modulate skeletal development through their distinct functions and expression patterns

Journal of Cell Science

Volumn 129, Issue 5, 2016, Pages 1018-1030

  Ishikawa, Masaki ^a,b   Williams, Geneva L ^a,c   Ikeuchi, Tomoko ^a   Sakai, Kiyoshi ^a,d   Fukumoto, Satoshi ^b   Yamada, Yoshihiko ^a  

^a NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH   (United States)

^b TOHOKU UNIVERSITY   (Japan)

^c WASHINGTON UNIVERSITY   (United States)

^d NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Chondrocyte; Connexin 43; Ossification; Osteoblast; Pannexin 3; Skeletal formation

Indexed keywords

BETA CATENIN; CONNEXIN 43; GAP JUNCTION PROTEIN; PANNEXIN 3; UNCLASSIFIED DRUG; VASCULOTROPIN; WNT PROTEIN; GJA1 PROTEIN, MOUSE; PANNEXIN 3 PROTEIN, MOUSE;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE DENSITY; BONE DEVELOPMENT; CALVARIA; CARTILAGE CELL; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; DWARFISM; ENCHONDRAL OSSIFICATION; ENDOPLASMIC RETICULUM; IN VIVO STUDY; MOUSE; NEWBORN; NONHUMAN; OSTEOBLAST; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SKELETON MALFORMATION; ANIMAL; C57BL MOUSE; CHONDROCYTE; CYTOLOGY; EPIPHYSIS PLATE; GENE EXPRESSION REGULATION; GROWTH, DEVELOPMENT AND AGING; KNOCKOUT MOUSE; METABOLISM; OSTEOCLAST; PHYSIOLOGY; SIGNAL TRANSDUCTION; SKULL; TIBIA;

ANIMALS; CELL PROLIFERATION; CHONDROCYTES; CONNEXIN 43; CONNEXINS; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GROWTH PLATE; MICE, INBRED C57BL; MICE, KNOCKOUT; OSTEOBLASTS; OSTEOCLASTS; OSTEOGENESIS; SIGNAL TRANSDUCTION; SKULL; TIBIA;

EID: 84960432080     PISSN: 00219533     EISSN: 14779137     Source Type: Journal    
DOI: 10.1242/jcs.176883     Document Type: Article

References (39)

1. Almeida, M., Han, L., Bellido, T., Manolagas, S. C. and Kousteni, S. (2005). Wnt proteins prevent apoptosis of both uncommitted osteoblast progenitors and differentiated osteoblasts by beta-catenin-dependent and-independent signaling cascades involving Src/ERK and phosphatidylinositol 3-kinase/AKT. J. Biol. Chem. 280, 41342-41351.
2. Arikawa-Hirasawa, E., Watanabe, H., Takami, H., Hassell, J. R. and Yamada, Y. (1999). Perlecan is essential for cartilage and cephalic development. Nat. Genet. 23, 354-358.
3. Baranova, A., Ivanov, D., Petrash, N., Pestova, A., Skoblov, M., Kelmanson, I., Shagin, D., Nazarenko, S., Geraymovych, E., Litvin, O. et al. (2004). The mammalian pannexin family is homologous to the invertebrate innexin gap junction proteins. Genomics 83, 706-716.
4. Barbe, M. T., Monyer, H. and Bruzzone, R. (2006). Cell-cell communication beyond connexins: the pannexin channels. Physiology 21, 103-114.
5. Berridge, M. J., Lipp, P. and Bootman, M. D. (2000). The versatility and universality of calcium signalling. Nat. Rev. Mol. Cell Biol. 1, 11-21.
6. Bond, S. R., Lau, A., Penuela, S., Sampaio, A. V., Underhill, T. M., Laird, D. W. and Naus, C. C. (2011). Pannexin 3 is a novel target for Runx2, expressed by osteoblasts and mature growth plate chondrocytes. J. Bone Miner. Res. 26, 2911-2922.
7. Chung, D. J., Castro, C. H. M., Watkins, M., Stains, J. P., Chung, M. Y., Szejnfeld, V. L., Willecke, K., Theis, M. and Civitelli, R. (2006). Low peak bone mass and attenuated anabolic response to parathyroid hormone in mice with an osteoblastspecific deletion of connexin43. J. Cell Sci. 119, 4187-4198.
8. Civitelli, R. (2008). Cell-cell communication in the osteoblast/osteocyte lineage. Arch. Biochem. Biophys. 473, 188-192.
9. Costell, M., Gustafsson, E., Aszódi, A., Mörgelin, M., Bloch, W., Hunziker, E., Addicks, K., Timpl, R. and Fässler, R. (1999). Perlecan maintains the integrity of cartilage and some basement membranes. J. Cell Biol. 147, 1109-1122.
10. D'Hondt, C., Ponsaerts, R., De Smedt, H., Bultynck, G. and Himpens, B. (2009). Pannexins, distant relatives of the connexin family with specific cellular functions? Bioessays 31, 953-974.
11. Giepmans, B. N. (2004). Gap junctions and connexin-interacting proteins. Cardiovasc. Res. 62, 233-245.
12. Hervé, J.-C. and Derangeon, M. (2013). Gap-junction-mediated cell-to-cell communication. Cell Tissue Res. 352, 21-31.
13. Hesse, E., Saito, H., Kiviranta, R., Correa, D., Yamana, K., Neff, L., Toben, D., Duda, G., Atfi, A., Geoffroy, V. et al. (2010). Zfp521 controls bone mass by HDAC3-dependent attenuation of Runx2 activity. J. Cell Biol. 191, 1271-1283.
14. Huang, G. Y., Cooper, E. S., Waldo, K., Kirby, M. L., Gilula, N. B. and Lo, C. W. (1998). Gap junction-mediated cell-cell communication modulates mouse neural crest migration. J. Cell Biol. 143, 1725-1734.
15. Ishijima, M., Suzuki, N., Hozumi, K., Matsunobu, T., Kosaki, K., Kaneko, H., Hassell, J. R., Arikawa-Hirasawa, E. and Yamada, Y. (2012). Perlecan modulates VEGF signaling and is essential for vascularization in endochondral bone formation. Matrix Biol. 31, 234-245.
16. Ishikawa, M., Iwamoto, T., Nakamura, T., Doyle, A., Fukumoto, S. and Yamada, Y. (2011). Pannexin 3 functions as an ER Ca(2+) channel, hemichannel, and gap junction to promote osteoblast differentiation. J. Cell Biol. 193, 1257-1274.
17. Ishikawa, M., Iwamoto, T., Fukumoto, S. and Yamada, Y. (2014). Pannexin 3 inhibits proliferation of osteoprogenitor cells by regulating Wnt and p21 signaling. J. Biol. Chem. 289, 2839-2851.
18. Iwamoto, T., Nakamura, T., Doyle, A., Ishikawa, M., de Vega, S., Fukumoto, S. and Yamada, Y. (2010). Pannexin 3 regulates intracellular ATP/cAMP levels and promotes chondrocyte differentiation. J. Biol. Chem. 285, 18948-18958.
19. Karsenty, G. and Wagner, E. F. (2002). Reaching a genetic and molecular understanding of skeletal development. Dev. Cell 2, 389-406.
20. Kato, M., Patel, M. S., Levasseur, R., Lobov, I., Chang, B. H.-J., Glass, D. A., II, Hartmann, C., Li, L., Hwang, T.-H., Brayton, C. F. et al. (2002). Cbfa1-independent decrease in osteoblast proliferation, osteopenia, and persistent embryonic eye vascularization in mice deficient in Lrp5, a Wnt coreceptor. J. Cell Biol. 157, 303-314.
21. Koga, T., Matsui, Y., Asagiri, M., Kodama, T., de Crombrugghe, B., Nakashima, K. and Takayanagi, H. (2005). NFAT and Osterix cooperatively regulate bone formation. Nat. Med. 11, 880-885.
22. Kopp, H. G., Hooper, A. T., Shmelkov, S. V. and Rafii, S. (2007). Betagalactosidase staining on bone marrow. The osteoclast pitfall. Histol. Histopathol. 22, 971-976.
23. Kronenberg, H. M. (2003). Developmental regulation of the growth plate. Nature 423, 332-336.
24. Lecanda, F., Warlow, P. M., Sheikh, S., Furlan, F., Steinberg, T. H. and Civitelli, R. (2000). Connexin43 deficiency causes delayed ossification, craniofacial abnormalities, and osteoblast dysfunction. J. Cell Biol. 151, 931-944.
25. Lustig, B., Jerchow, B., Sachs, M., Weiler, S., Pietsch, T., Karsten, U., van de Wetering, M., Clevers, H., Schlag, P. M., Birchmeier, W. et al. (2002). Negative feedback loop of Wnt signaling through upregulation of conductin/axin2 in colorectal and liver tumors. Mol. Cell. Biol. 22, 1184-1193.
26. Matsunobu, T., Torigoe, K., Ishikawa, M., de Vega, S., Kulkarni, A. B., Iwamoto, Y. and Yamada, Y. (2009). Critical roles of the TGF-beta type I receptor ALK5 in perichondrial formation and function, cartilage integrity, and osteoblast differentiation during growth plate development. Dev. Biol. 332, 325-338.
27. Nakashima, K., Zhou, X., Kunkel, G., Zhang, Z., Deng, J. M., Behringer, R. R. and de Crombrugghe, B. (2002). The novel zinc finger-containing transcription factor osterix is required for osteoblast differentiation and bone formation. Cell 108, 17-29.
28. Paznekas, W. A., Boyadjiev, S. A., Shapiro, R. E., Daniels, O., Wollnik, B., Keegan, C. E., Innis, J. W., Dinulos, M. B., Christian, C., Hannibal, M. C. et al. (2003). Connexin 43 (GJA1) mutations cause the pleiotropic phenotype of oculodentodigital dysplasia. Am. J. Hum. Genet. 72, 408-418.
29. Plotkin, L. I., Lezcano, V., Thostenson, J., Weinstein, R. S., Manolagas, S. C. and Bellido, T. (2008). Connexin 43 is required for the anti-apoptotic effect of bisphosphonates on osteocytes and osteoblasts in vivo. J. Bone Miner. Res. 23, 1712-1721.
30. Reaume, A. G., de Sousa, P. A., Kulkarni, S., Langille, B. L., Zhu, D., Davies, T. C., Juneja, S. C., Kidder, G. M. and Rossant, J. (1995). Cardiac malformation in neonatal mice lacking connexin43. Science 267, 1831-1834.
31. Rodda, S. J. and McMahon, A. P. (2006). Distinct roles for Hedgehog and canonical Wnt signaling in specification, differentiation and maintenance of osteoblast progenitors. Development 133, 3231-3244.
32. Seo, J. H., Jin, Y.-H., Jeong, H. M., Kim, Y.-J., Jeong, H. G., Yeo, C.-Y. and Lee, K.-Y. (2009). Calmodulin-dependent kinase II regulates Dlx5 during osteoblast differentiation. Biochem. Biophys. Res. Commun. 384, 100-104.
33. Söhl, G. and Willecke, K. (2004). Gap junctions and the connexin protein family. Cardiovasc. Res. 62, 228-232.
34. Tucker, R. P. (1993). The in situ localization of tenascin splice variants and thrombospondin 2 mRNA in the avian embryo. Development 117, 347-358.
35. van der Heyden, M. A., Rook, M. B., Hermans, M. M., Rijksen, G., Boonstra, J., Defize, L. H. and Destree, O. H. (1998). Identification of connexin43 as a functional target for Wnt signalling. J. Cell Sci. 111, 1741-1749.
36. Vanden Abeele, F., Bidaux, G., Gordienko, D., Beck, B., Panchin, Y. V., Baranova, A. V., Ivanov, D. V., Skryma, R. and Prevarskaya, N. (2006). Functional implications of calcium permeability of the channel formed by pannexin 1. J. Cell Biol. 174, 535-546.
37. Watkins, M., Grimston, S. K., Norris, J. Y., Guillotin, B., Shaw, A., Beniash, E. and Civitelli, R. (2011). Osteoblast connexin43 modulates skeletal architecture by regulating both arms of bone remodeling. Mol. Biol. Cell 22, 1240-1251.
38. Zayzafoon, M. (2006). Calcium/calmodulin signaling controls osteoblast growth and differentiation. J. Cell Biochem. 97, 56-70.
39. Zelzer, E., McLean, W., Ng, Y. S., Fukai, N., Reginato, A. M., Lovejoy, S., D'Amore, P. A. and Olsen, B. R. (2002). Skeletal defects in VEGF(120/120) mice reveal multiple roles for VEGF in skeletogenesis. Development 129, 1893-1904.